George C. Clark, VP, Chief Accounting Officer at Biohaven Pharmaceutical Holding Co Ltd. (BHVN), sold 3,830 shares at $123.84 ($474K) on 2021-12-20, disclosed to the SEC on 2021-12-22.
Open-market sale of $474k BHVN by VP, Chief Accounting Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $123.84 | 1,915 | $237K | 50.0% |
| 2 | $123.84 | 1,915 | $237K | 50.0% |
| Total | $123.84 avg | 3,830 | $474K | 100% |
| Filing → |
| BHVN | SELL | 2022-01-24 | $2.1M | — | Filing → |